Synapticure: Funding, Investors & Team (Sep 2026)
Synapticure brings expert virtual care to individuals and caregivers living with neurodegenerative diseases, including Parkinson's, Alzheimer's and related dementia, ALS, and more conditions. Our mission is to democratize access to cutting-edge and personalized care provided by neurologists, mental health providers, and care navigators here for you 24/7.
Synapticure has raised $65.1M across 2 funding rounds on record, the most recent a Series A of $25.0M announced in Nov 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Synapticure Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Synapticure Funding Rounds
Synapticure raised $40.1M in an undisclosed round announced in Sep 2024.
2 months later, a Series A of $25.0M was announced in Nov 2024.
Synapticure Founders and Leadership Team
No contact details are on record for this team yet.
Synapticure Funding Compared to Other Biotechnology Startups
Synapticure's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synapticure in Biotechnology and Chicago
Companies Similar to Synapticure
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Synapticure Funding FAQs
What does Synapticure do?
Synapticure brings expert virtual care to individuals and caregivers living with neurodegenerative diseases, including Parkinson's, Alzheimer's and related dementia, ALS, and more conditions. Our mission is to democratize access to cutting-edge and personalized care provided by neurologists, mental health providers, and care navigators here for you 24/7.
How much funding has Synapticure raised?
Synapticure has raised $65.1M across 2 rounds on record. The most recent is a Series A of $25.0M announced in Nov 2024.
When did Synapticure last raise funding?
Synapticure's most recent funding round on record is a Series A of $25.0M, announced in Nov 2024.
Who founded Synapticure?
FundedIQ lists Peter Wallach (Founder) at Synapticure.
Where is Synapticure headquartered?
Synapticure is based in Chicago, Illinois, United States.
How many employees does Synapticure have?
Synapticure is in the 11-50 employee band.
How does Synapticure's funding compare to other Biotechnology startups?
Synapticure's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Synapticure Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synapticure is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.